This statistic displays the leading Medicare Part B cancer drugs based on average sales price per dosage in 2014, in U.S. dollars. The average sales price for one dose (1 mg) of a Denosumab injection totaled 14.45 U.S. dollars. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the United States.
Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in U.S. dollars)
This statistic displays the leading Medicare Part B cancer drugs based on average sales price per dosage in 2014, in U.S. dollars. The average sales price for one dose (1 mg) of a Denosumab injection totaled 14.45 U.S. dollars. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the United States.
Loading statistic...
| Name (dose) | Sales price per dosage in U.S. dollars |
|---|---|
| Pegfilgrastim injection* (6mg) | 3,387.93 |
| Aflibercept injection* (0.1mg) | 980.5 |
| Rituximab injection* (100mg) | 708.68 |
| Ranibizumab injection (0.1mg) | 396.43 |
| Trastuzumab injection* (10mg) | 82.49 |
| Infliximab injection (10mg) | 74.34 |
| Bevacizumab injection* (10mg) | 66.65 |
| Pemetrexed injection* (10mg) | 60.27 |
| Bortezomib injection* (0.1mg) | 46.08 |
| Denosumab injection* (1mg) | 14.45 |
© Statista 2018
More information
Other interesting statistics
+Italy: new cancer cases among males 2018, by type of cancer
+Italy: new cancer cases among females 2018, by type of cancer
+Italy: number of new cancer cases among females 2018, by region
+Italy: breast cancer mortality rate 2015, by region
+Italy: cinque per mille allocated to Istituto Europeo di Oncologia 2013-2016
+Italy: funds raised by Italian Association for Cancer Research 2012-2017, by source
Statistics on "Cancer in Italy"
Popular Related Keywords
- average price
- Medicare
- cancer drugs
- dosage
- Medicare Part B
- Show more
- health
- health service
- health expert
- cancer
- medical care
- medical professions
- health index
- medical help
- medical profession
- medical practices
- health authorities
- health sector
- cancer case
- oncologist
- health market
- cancer prevalence
- medical industry
- medical staff
- medical
- oncology
- specialty
- cancer drug
- health centers
- medical facility
- health care provider
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Expensive cancer drugs by annual Medicare payments in the U.S. 2014
- Italy: oncologists' behavior when facing budgetary restraints 2018
- Italy: oncologists' behavior towards patients when facing budgetary restraints 2018
- Net price index for cancer products in developed markets 2014
- Concern over NHS provision of cancer drugs in the United Kingdom (UK) 2015, by age
- Rates of Medicare acceptance in select U.S. metropolitan areas by specialty 2013
- Medicare Part D payer share of branded and generic drugs by therapy area 2015
- Medicare Advantage enrollment in top ten states in the U.S. 2017
- Medicare hospital inpatient case charges by severity in the U.S. 2014
- U.S. average invoice price increase for oncology brands 2012-2017
- Enrollment of Medicare Advantage within Medicare 2004-2017
- Medicare hospital inpatient charges by disease in the U.S. 2016
- Penetration of Medicare Advantage into Medicare 2004-2017
- Compensation for U.S. physicians under Medicare HMOs by method 2015
- USA: Active ingredients in anti-cancer drugs 2004-2013
- Proportion of cancer drugs on the world pharmaceutical market
- Number of Medicare-certified ambulatory surgery centers by state 2016
- Growth in Medicare per capita spending compared to economic benchmarks 2011-2020
- Major chronic conditions in Medicare spending
